Complement Involvement in Renal Transplantation - European Medical Journal

Complement Involvement in Renal Transplantation

Download PDF
*Maurizio Salvadori,1 Giuseppina Rosso,2 Elisabetta Bertoni1

The authors have declared no conflicts of interest.

EMJ Nephrol. ;3[1]:63-69. DOI/10.33590/emjnephrol/10313449.
Renal transplantation, complement cascade, ischaemia—reperfusion injury, acute and chronic rejection, renal fibrosis, therapies targetting complement

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


The complement system is involved in several renal diseases and in renal transplantation (RTx). The authors review the complement cascade and its involvement in innate and adaptive immunity in the field of RTx. The complement cascade is involved in several steps of RTx: ischaemia—reperfusion injury (IRI), T cell-mediated acute rejection (TMR), antibody-mediated rejection (ABMR), and progressive kidney injury and fibrosis. The high frequency of complement involvement in RTx is the subject of several studies because complement could be a relevant target in treating the aforementioned conditions. There is an increasing number of ongoing clinical trials aimed at verifying the efficacy and safety of many drug candidates. The anti-C5 monoclonal antibody is already approved to prevent and treat ABMR and is the subject of trials investigating the treatment of other conditions such as IRI, TMR, and progressive fibrosis. Other molecular targets, such as C1, C3, C5a, and C5a receptor, are the subject of international trials and could prove to be effective in the near future.

Please view the full content in the pdf above.

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally